REACTIVE BIOSCIENCES INC
DURHAM, NC · Founded 2015 · CIK 0001700096 · Biotech · Private
Novel boron-containing small-molecule antimalarial compounds with benzoxaborole structures
- Grants
- $1.4M
- 2 awards
- Sector median: 1
- Raised
- $43M
- 5 Form D · Jun 2023
- 40 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 0 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $10,530,292 | |
| Private capital raised | Form D · SEC | $3,000,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $23,499,998 | |
| Private capital raised | Form D · SEC | $4,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Boron-containing antimalarial drug discovery | $952,800 | |
| Federal grant | Department of Health and Human Services · Phase II · Boron-containing antimalarial drug discovery | $464,495 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1754 | Aviceda Therapeutics | — | $99M |
| 1755 | PROTABIT, LLC | — | — |
| 1756 | LAMNOTHERAPEUTICS, INC. | — | — |
| 1757 | REACTIVE BIOSCIENCES INC | — | $43M |
| 1758 | Aerpio Therapeutics LLC | — | $45M |
| 1759 | SERINA THERAPEUTICS INC | — | $34M |
| 1760 | Iterative Therapeutics Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Stephen BenkovicDirector
- Kristina BurowDirector · Executive Officer
- John DombroskyExecutive Officer
- Peter FarinaDirector
- Rich GianniExecutive Officer
- Julie GrantDirector · Executive Officer
- Tracy JacksonExecutive Officer
- Raj KaulDirector
- Roger KembleDirector · Executive Officer
- Joel MarcusDirector
- Paul SchimmelDirector
- Esther van den BoomExecutive Officer
Patents
- Boron Compounds As PI3K Inhibitorsapplication
- Boron Compounds As PI3K Inhibitorsapplication
- Boron Compounds As PI3K Inhibitorsapplication
- Boron Derivatives As PI3K Inhibitorsapplication
- Boron Compounds As PI3K Inhibitorsapplication
- Boron Derivatives As PI3K Inhibitorsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.